At Simsen, we care

We envision a future where cancer is a curable disease. To achieve this, we aim to transform cancer care one blood sample at a time.

Get to know the people behind our solutions and services. Meet the leadership team and the managing board – these are the talented people driving Simsen Diagnostics towards a brighter future.

Leadership Simsen Diagnostics

Pontus Rehn has over 20 years of experience in commercial leadership roles in the medical device and IVD industries, including global and regional positions like VP Market Development, Chief Commercial Officer, and Director of Commercial Strategy. 

Pontus Rehn
Chief Executive Officer (CEO)

Stefan Filges, an accomplished bioinformatician with a Ph.D. in ultrasensitive sequencing, became part of Simsen Diagnostics in 2022. He played a crucial role as a co-author in the original publication of SiMSen-Seq, which was published in Nature Protocols.

Stefan Filges
Chief Technology Officer (CTO)

Jonna Eriksson holds a Ph.D. in genomics, bioinformatics, botany and evolution and has extensive experience from quality management and regulatory policies. Previous roles include Ass. Prof. at University of Skövde and Sr. R&D researcher at TATAA Biocenter.

Jonna Eriksson
Quality Assurance / Regulatory Affairs Manager (QA/RA)

Camilla Hietanen holds an M.Sc. in Business Development from the Chalmers School of Entrepreneurship. Her academic background encompasses studies in Sports & Nutrition, and she brings prior experience from various Start-ups. Within Simsen Diagnostics, her primary focus lies in Sales and Marketing. 

Camilla Hietanen
Head of Sales and Marketing

As our Research Engineer with an M.Sc. in Biotechnology, My integrates scientific expertise into R&D and customer projects. With previous tutoring experience in bioanalytics, she now oversees all sample handling and laboratory procedures. She has also taken on the role of Project Manager, ensuring project execution.

My Vu
Research & Lab Manager

Niki Rostamzadeh leverages his prior experience with founder Anders Ståhlberg’s team, bringing a deep understanding of our technology to his current role. As our Research Engineer, he is responsible for managing R&D experiments and overseeing the handling of customer samples.

Niki Rostamzadeh
Research Engineer

Board and founders

andersw

Anders Waas
Business advisor
Anders Waas is a business developer and investment manager at GU Venture with experience establishing start-ups in the life science sector. Anders has over 30 years of experience in the pharmaceutical and biotechnology industry as an advisor and CEO for multiple companies. He previously worked at the multinational pharmaceutical company AstraZeneca as a business developer and marketing director for over 13 years.

mikaelc

Mikael Kubista
PhD – Co-founder, former CEO TATAA Biocenter 
Mikael Kubista is co-founder and former CEO of TATAA Biocenter and an expert in molecular technologies, and co-author of the MIQE guidelines. Mikael has business development skills within Bioinformatics, Real-Time Polymerase Chain Reaction (qPCR), Protein Chemistry Medical devices and RNA Isolation. In addition, Mikael has proven track record of developing biotech companies, including Life Genomics and Gendoktorn.

tonyc

Tony Godfrey
PhD – Co-founder
Tony Godfrey is professor at the Department of Surgery and Computational Biomedicine at Boston University School of Medicine. Tony co-invented SiMSen-Seq and developed further improvements of the technique. In addition, Tony has been an associate professor at several well-known universities in the US, such as the University of Rochester, The Mount Sinai Hospital, and the University of Pittsburgh.

christina-hall

Christina Hall
PhD – Senior Advisor, Fujirebio Diagnostics AB
Christina has been the CEO of Fujirebio Diagnostics AB for more than 14 years and has held management roles with similar diagnostics companies. Earlier, she has served as assistant professor of histology with the University of Gothenburg.

hanna-mann

Hanna Mann
Business Development Manager, Olink Proteomics
Hanna is a seasoned professional with over 15 years of experience in the life science industry. With a background in molecular biology, she has successfully navigated various roles including commissioned research, sales management, sales enablement, and business development. Hanna’s primary focus is on driving the application of biomarkers in clinical settings, aiming to enhance healthcare outcomes.

artur aira

Artur Aira
CEO, Active Health
Artur is the CEO of Active Health. He is an experienced leader with more than 25 years of experience from pharma, diagnostics and biotechnology companies. Previous positions include CEO of Abigo Medical and SVP and BA manager of BICO. In addition, Artur has served on more than 30 company boards.

Dominique Goudy

Dominique Goudy
PhD - Partner, Care Equity
Dominique is a Partner at Care Equity with over 20 years of experience in healthcare industry. Previous roles include CSO at BioAgilytix, Global Business Line Leader at Intertek and roles at Centocor, Amylin and Eli Lilly. She holds multiple patents and has published numerous peer-reviewed papers. She earned her PhD in Endocrinology from the University Timone Aix-Marseille II, School of Medicine, in France

Pontus Rehn

Chief Executive Officer (CEO)

Pontus Rehn has over 20 years of experience in commercial leadership roles in the medical device and IVD industries, including global and regional positions like VP Market Development, Chief Commercial Officer, and Director of Commercial Strategy. 

Lina Said

Laboratory and Quality Manager

Lina Said, a licensed Biomedical Scientist, brings 18 years of experience from Sahlgrenska University Hospital to her role as the Lab and Quality Manager at Simsen Diagnostics. Her primary focus is ensuring quality assurance and fostering an optimal work environment for the lab. 

My Vu

Lead Laboratory Technician

My Vu is currently doing a master’s degree in biotechnology and demonstrates expertise in laboratory procedures. Her previous experience includes analyzing COVID samples and conducting her bachelor’s thesis at Fraunhofer. My is analyzing all the samples that comes to the lab.  

Stefan Filges

Chief Technology Officer (CTO)

Stefan Filges, an accomplished bioinformatician with a Ph.D. in ultrasensitive sequencing, became part of Simsen Diagnostics in 2022. He played a crucial role as a co-author in the original publication of SiMSen-Seq, which was published in Nature Protocols. 

Camilla Hietanen

Head of Sales and Marketing

Camilla Hietanen holds an M.Sc. in Business Development from the Chalmers School of Entrepreneurship. Her academic background encompasses studies in Sports & Nutrition, and she brings prior experience from various Start-ups. Within Simsen Diagnostics, her primary focus lies in Sales and Marketing. 

Almost there

Sign up on our maillist to gain access to your article. You can at any time unsubscribe from the list.